A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI
NCT05348772
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
AmnioPul-02
Sponsor
Amniotics AB